Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitoQ for doxorubicin-induced cardiotoxicity in breast cancer
NCT05146843Unknown
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Jun 2022
- Primary completion
- Nov 2022
01
Overview
Randomised, double-blind trial in Cardiotoxicity comparing Mitoquinone Arm with Placebo Arm (2 arms). Primary endpoint: Changes of the left ventricular deformity and reduction in left ventricular ejection fraction at 3 months. Status: unknown.
02
Drugs
mitoquinone
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT05146843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05146843.